Related Experiment Video
Updated: May 2, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Disarmed by density: A glycolytic break for immunostimulatory dendritic cells?
Aikaterini Nasi1, Bence Rethi1
1Department of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden.
Abstract:
We observed a cell concentration-dependent differentiation switch among cultured dendritic cells (DCs) triggered by lactic acid, a product of glycolytic metabolism. In particular, while interleukin (IL)-12, IL-23, and tumor necrosis factor α (TNFα)-producing, migratory DCs developed in sparse cultures, IL-10-producing, non-migratory DCs differentiated in dense cultures. This points to a novel opportunity for tailoring DC-based anticancer therapies through metabolism modulation in developing DCs.

